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Abstract  
Tablets at present, remain the most preferred oral dosage form because of many advantages they offer 
to formulators as well as physicians and patients. The objective of this work was to determine the effect 
of co-processing on the disintegration and drug-release profile of ibuprofen tablets prepared from a co-
processed excipient. The co-processed excipient (CE) containing lactose, gelatin and mucin in the ratio 
90:9:1 was prepared using co-fusion. The excipient was evaluated for its physicochemical properties 
and then used to formulate tablets with the addition of a disintegrant by direct compression. The tablets 
were evaluated for their tablet properties and compared with tablets prepared with cellactose- 80® (CEL) 
and spray dried lactose® (SDL) and a physical mix (PM) of the co-processed ingredient. Results from 
evaluation of CE showed that flow rate, angle of repose, Carr’s index and Hausner’s ratio were 5.28 
g/sec, 20.30o, 23.75 % and 1.31, respectively. Tablets prepared with CE had friability (0%), crushing 
strength (5.25) KgF, disintegration time (3 mins) and T50% (2 mins). For CEL, friability (0.4 %), crushing 
strength (7.25) KgF, disintegration time (1 min) and T50% (2 mins); SDL, friability (1.57 %), crushing 
strength (7.50) KgF, disintegration time (4 mins) and T50% (2 mins) and PM, friability (2.38 %), crushing 
strength (5.00) KgF, disintegration time (1 min) and T50% (2 mins). In conclusion, the disintegration time 
and drug release profile for CE was not superior but compared favorably with CEL, SDL and PM. 
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Drug administration, through the oral route has 
been very popular for the usage of medicinal 
agents in managing diseases since it gives 
room for safety, permits self-medication, ease 
of ingestion of drug product, etc. and these 
enhance patient compliance (Quodbach and 
Kleinebudde, 2016).The large surface area of 
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absorption, provides sufficient fluid to facilitate 
disintegration of the dosage form and 
dissolution of the drug thereby making the oral 
route the most appealing route for drug delivery 
despite the advancements made in the new 
drug delivery systems (Desai et al., 2016). 
According to Banker and Anderson, at least 
90% of all drugs used to produce systemic 
effect are administered orally. Currently, 
controlled release and targeted drug delivery 
systems seem to be getting much attention 
within the solid dosage forms, although, solid 
dosage forms which when ingested, 
disintegrate to discharge their active 
pharmaceutical ingredients (API) instantly in 
the gastrointestinal tract have continued to 
enjoy much patronage. The tablet disintegration 
process is very critical for the immediate 
release dosage forms and consequent upon 
that, disintegrants are added to tablets to 
induce break-up when it comes in contact with 
the fluid (Sastry et al., 2000). A disintegrant is 
described as an inert substance that is added 
to a solid dosage formulation such as a tablet 
or capsule to cause their breakup that will lead 
to the release and dissolution of the API. They 
act by increasing the surface area of the tablet 
and softening the binding agent through 
swelling which is often accepted as the key 
mechanism of tablet disintegration. This on its 
own, enhances the rate of dissolution in the 
media (Sharma et al., 2019). Currently, starch 
and cellulose-based materials among others 
are utilized as disintegrants and could be 
incorporated intragranularly, extragranularly or 
by both procedures especially in a wet 
granulation method of producing tablets (Dave, 
2008). Methods of producing uncoated tablets 
intended for rapid disintegration and release of 
the API could be wet granulation (WG), dry 
granulation (DG) or direct compression (DC) 
methods. The use of the DC method is currently 
widespread because its mode of application is 
simple and achievable in the shortest possible 
time frame. Its utilization enhances a cautious 
choice of an excipient which should 
demonstrate impressive flowability and 
compressibility (Gandhi and Akhtar, 2019). 
New combinations of existing excipients are 
interesting option for improving excipient 
functionality because all formulations contain 
multiple excipients. A much broader platform for 
the manipulation of excipient functionality is 
provided by co-processing or particle 
engineering of two or more excipients. 
Co-processing, which is based on the novel 
concept of two or more excipients interacting at 
sub particle level, with an objective of providing 
a synergy of functionality improvement as well 
as masking the undesirable properties of the 
individual excipients has become a method of 
interest because the products are in a special 
way physically modified without losing their 
chemical structure and stability (Nachaegari 
and Bansal, 2004). This concept of co-
processing of excipients was introduced in late 
1980s when microcrystalline cellulose and 
calcium carbonate were co-processed (Mehra 
et al., 1988).  
Previous studies on co-processing lactose, 
gelatin and mucin in the formulation of 
ibuprofen tablets exhibited superior 
characteristics required for tableting when 
compared to its parent excipient (lactose 
monohydrate) and the physical mix but 
however, failed disintegration as well as 
dissolution tests due to poor release, therefore, 
the aim of this research is to prepare a novel 
pharmaceutical excipient using the simple 
method of co-processing with the incorporation 
of a disintegrant (corn starch) and to determine 
its effect on the release profile of ibuprofen from 
tablets (Mohammed, 2017). 
MATERIALS AND METHODS  
Materials  
Lactose, Maize starch (BDH Pharmaceuticals, 
Mumbai, India) Cellactose-80, Spray dried 
lactose (Ausmasco Chemicals Ltd, Xiamen-
Fujia, China) Gelatin (May and Baker Ltd, 
Dagenham, England) Ibuprofen (Himedia 
laboratories Ltd, Mumbai, India). All other 
reagents used were of analytical grade and 
water was double distilled. 
Extraction of mucin  
The extraction of mucin has been previously 
reported by Mohammed and Apeji., (2018) 
using fresh small intestines of cow obtained 
from the abbatoir (Zango, Kaduna) and 
dissected starting from the beginning of the 
jejunum to the ileocaecal sphincter. The 
intestines sectioned into short lengths was 
flushed through with chilled saline and the 
mucosal surface was exposed by longitudinal 
dissection. Using a microscope slide, the 
mucus layer was gently scrapped off into the 
chilled saline. The mucus was precipitated 
using chilled acetone and dried (lyophilized). 
The resultant flakes were pulverized using a 
milling machine and stored in an air-tight 
container until used.  
Excipient preparation  
The preparation of excipient has been 
previously reported in Mohammed and Apeji., 
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described by Adeoye and Alebiowu, 2014, a 
mix of lactose, gelatin and mucin was carried 
out in the ratio 90:9:1 by dispersing them in 
distilled water and heated on a water bath at 
40OC for 15 mins following an outcome of a pre-
formulation study using the design of 
experiment (DOE).  
Powder characterization 
Angle of repose 
The static angle of repose θ was measured 
according to the fixed funnel and free-standing 
cone method (Ohwoavworhua and Adelakun, 
2005). A funnel was clamped with its tip 2cm 
above a graph paper placed on a flat horizontal 
surface. The powders were carefully poured 
through the funnel until the apex of the cone 
thus formed just reached the tip of the funnel. 
The heights (b) of the powder cones and the 
mean diameters (D) of the base of powder 
cones were determined and the tangent of the 





Bulk and tapped densities 
A 2.0g quantity each of the powder sample was 
placed in a 10ml measuring cylinder and the 
volume, V0 occupied by each of the samples 
without tapping was noted. After 100 taps on 
the table, the occupied volume V100 was read. 
The bulk and tapped densities were calculated 
as the ratio of the weight to volume (V0 and 
V100 respectively). 
Compressibility Index  
 𝐶𝑜𝑚𝑝𝑟𝑒𝑠𝑠𝑖𝑏𝑖𝑙𝑖𝑡𝑦 𝑖𝑛𝑑𝑒𝑥 =
𝑇𝑎𝑝𝑝𝑒𝑑 𝑑𝑒𝑛𝑠𝑖𝑡𝑦−𝑏𝑢𝑙𝑘 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
𝑇𝑎𝑝𝑝𝑒𝑑 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
 × 100…………… (ii) 
 
Hausner’s ratio  
This was calculated as the ratio of tapped 
density to bulk density of the samples. The 
same powder parameters evaluated for CE was 
repeated for the other powder blends and are 
referred to as formulations I, II, III and IV. 
Tablet formulation  
The powders were compressed into tablets 
using a single punch tableting machine (Erweka 
GmbH, Langen, Germany) at different 
compression pressures ranging from 5-7 MT to 
produce 500 mg tablets. Four different 
formulations were prepared by direct 




Table 1: Tablet formula 
Ingredients (mg)                 I                       II                      III                    IV              
Ibuprofen                              200                    200                    200                   200 
Excipient                               282                    282                    282                   282 
Maize starch                          15                       15                      15                     15 
Magnesium stearate              3                         3                        3                        3 
Total                                       500                   500                     500                  500 
Key: I= Co-processed excipient (CE), II = Cellactose-80 (CEL), III = Spray dried lactose (SDL), IV = Physical mix (PM) 
 
Tablet evaluation  
Friability 
This was determined using a Roche friabilator 
as described in the USP 32/NF 27 (2009). Ten 
tablets were weighed (X) and transferred to the 
friability test apparatus at 25 rpm for 4 min. The 
tablets were removed, de-dusted and re-
weighed (Y). 
Disintegration test 
The assembly (Erweka, Langen, Germany) was 
suspended in a 1000 mL beaker containing 
distilled water. The volume of liquid was taken 
such that when the assembly was in highest 
position the wire mesh was at least 25 mm 
below the surface of the liquid and when the 
Assembly was in lowest position the wire mesh 
was at least 25 mm above the bottom of the 
beaker. One tablet was placed into each of the 
six tubes. The apparatus was operated with the 
BP method having the minimum expected time 
for disintegration as 15 mins, 900 mL of distilled   
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water and temperature at 37±2 °C. Time for 
complete disintegration of tablet was noted. 
In-vitro drug release studies 
The dissolution profiles of Ibuprofen tablets 
were determined using the USP XXVIII basket 
method for the various batches of the tablets. A 
dissolution medium of 900 mL of phosphate 
buffer pH 7.2 solution for Ibuprofen maintained 
at (37±0.5) o C with a basket revolution of 50 
r/min was used (USP/NF, 2009). A 5 mL volume 
of leaching fluid was withdrawn at 
predetermined time intervals (5, 10, 15, 20, 25 
min) and replaced with an equivalent volume of 
the dissolution medium after each withdrawal. 
The withdrawn samples were filtered and 
diluted with an equal volume of phosphate 
buffer pH 7.2 solution. This was continued for 
60 min.  
The absorbance of the resulting solutions was 
measured spectrophotometrically at λ max 221 
nm for ibuprofen. The percentage drug 
released at each interval was determined using 
the equation from the standard calibration plot 
obtained for the pure drug. 
Statistical analysis 
All data obtained were expressed as mean ± 
SD. Statistical analysis was performed with 
one-way analysis of variance (ANOVA) 
comparison test of Graph pad prism 6. A 
confidence level of 95 % (ρ < 0.05) was 
considered satisfactory for determining 
significant differences. 
RESULTS AND DISCUSSION  
The powders so formed in the tablet formulation 
were observed to have excellent flow properties 
as presented on Table 2 with angles of repose 
of < 300, except that of formulation IV that has 
value of 54.660.  
For good flow of granules, the British 
Pharmacopoeia (2010) specifies Hausner’s 
ratio value of <1.25, Carr’s index of > 5 ≤ 16. 
The Hausner’s ratio for formulations I, II and III 
were within the standard specification. Carr’s 
index for the granules for formulation III 
revealed good flow character, formulations I 
and II revealed passable flow character while 
formulation IV has very poor flow character.  
For poorer flowing materials, there are 
frequently greater interparticle interactions and 
a greater difference between the bulk and 
tapped densities will be observed (Ajay et al., 
2012). Formulation IV had the highest 
difference (0.29 g/cm3) between bulk and 
tapped densities as seen on Table 2 compared 
to I (0.19 g/cm3), II (0.12 g/cm3) and III 
(0.13g/cm3). Therefore, formulation IV exhibited 
poor flow compared to formulations I, II and III 
with good flow. This goes a long way to show 
that co-processing or particle manipulation did 
not in any way result in the formation of a new 
compound and this is comparable to the work 
of Gramaglia et al (2005). 
 
 
Table 2:  Micromeritic and flow properties of ibuprofen and excipients’ mix 
 
Properties                       CE                          CEL                       SDL                         PM 
Flow rate (g/sec.)            5.28 (0.01)               4.62(0.1)               6.25(0.03)               1.46 (0.2) 
Angle of repose (0)          20.30 (0.55)             14.57(0.57)           17.22(0.1)                54.66 (3.18) 
Bulk density (g/ml)          0.61 (0.43)                0.44(0.0)              0.74(0.0)                  0.51 (0.03)           
Tapped density (g/ml)     0.80 (0.01)                0.56(0.0)              0.87(0.03)                0.80 (0.03)                   
Carr’s index (%.)             23.75 (0.6)                21.43(0.01)          14.92(0.0)                36.25 (0.5) 
Hausner’s ratio                1.31 (0.27)                1.27(0.1)              1.18(0.11)                1.57 (0.57) 
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Key: -I-Co-processed excipient; T50%-Time taken to release 50 % of the drug;  II-Cellactose – 80; T90%:-Time taken to release 
90 % of the drug; III-  Spray dried lactose; ND-Not determined; IV-  Physical mix; CS- Crushing Strength; TS-Tensile Strength;                              
BI-Bonding Index; FR-Friability; DT-Disintegration Time 
 
 
The values for the average weight of tablets 
with reference to Table 3 for all formulations 
compressed were within B.P (2010) 
specification of ± 5 %. A 12 mm punch was 
used, and the diameter of the tablets 
corresponded with this size. Thickness which is 
dependent on the volume of the die cavity, 
showed that the tablets had a thickness of 
approximately 4.17 mm – 4.50 mm. The 
crushing strength values ranged between 5 to 
7.5 KgF which was within the accepted limit of 
4 – 8 KgF, to enable the tablets disintegrate at 
a definite rate and withstand handling during 
packaging. The result of tablets friability test 
showed that formulations I and II had a friability 
value of < 1.0 %, while formulations III and IV 
had a friability of >1.0 % (1.57% and 2.38% 
respectively).   
 
This is explained by the fact that formulations III 
and IV as seen on table 3 did not go through co-
processing, therefore, implying that co-
processing enhances bonding and decreases 
the formation of friable tablets.  The tablets 
disintegration time complied with B.P (2012) 
that uncoated tablets are expected to 
disintegrate within 15 min. The same amount of 
disintegrant (5% maize starch) was used for all 
formulations. All the tablets of the four 
formulations disintegrated in less than 5 mins 
which is a plus for conventional tablets. The 
disintegration test result is an improvement on 
the work done by Mohammed, (2017) in which 
the novel co-processed excipient (CE) failed 
the disintegration test having a disintegration 
time longer than 30 mins.  
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The drug release profile for CE, CEL and SDL 
as seen in figure 1 revealed that more than 70 
% of the drug was released after a time period 
of 45 min. In SDL and CE however, more than 
80 % of the drug was released, this agrees with 
the specification for drug release as indicated in 
the monograph for ibuprofen (USP/NF, 2009). 
The time taken to achieve 50 % drug release 
was same for all (CE, CEL and SDL) due 
probably to the rapid disintegration time 
observed. The extent of drug release by CE 
was higher than those of CEL and SDL, with CE 
exhibiting superior tensile strength. However, 
figure 1 result depicted that there was no 
complete release for any of the formulations 
due to known poor solubility of ibuprofen in 
water. This incomplete dissolution of the 
particles may have been affected by the 
intrinsic properties of the drug, its size and 
components of its formulation (Azam and 
Haider, 2008). 
CONCLUSION 
The disintegration time and drug release profile 
for formulation I (CE) was not superior to but 
compared favorably with formulations II (CEL), 
III (SDL) and IV (PM). However, due to the 
known poor solubility of ibuprofen in water, 
there was no complete release for any of the 
formulations. In conclusion, co-processing 
impacted greatly by improving the release 
profile of ibuprofen. 
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